|

Diabetes Clinical Trials in Raleigh, NC

51 recruiting studies within 50 miles

Phase
Trial Phase Dist.
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Phase 3<1 mi
A Food As Medicine Approach to Address Food Insecurity in Rural North CarolinaN/A<1 mi
Assessment of AI Program 'DRISTi' as a Screening Tool—<1 mi
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or OverweightPhase 3<1 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TLPhase 4<1 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot UlcersN/A<1 mi
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot UlcersN/A<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesPhase 3<1 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusPhase 2<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing DialysisPhase 2/3<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 38 mi
Personalized Environment and Genes Study—15 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1DPhase 121 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A21 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)N/A21 mi
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.Phase 121 mi
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 DiabetesN/A21 mi
Intraoperative OCT Guidance of Intraocular Surgery II—21 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 421 mi
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US—21 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)N/A21 mi
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic SyndromePhase 321 mi
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot UlcersPhase 221 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 421 mi
Food as Medicine for HIV and DiabetesN/A25 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)Phase 225 mi
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMARTN/A25 mi
Kidney Precision Medicine Project—25 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePhase 325 mi
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)N/A25 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 325 mi
CGM for Management of Type 2 Diabetes in PregnancyN/A25 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 225 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPhase 325 mi
Pilot of Continuous Glucose Monitor-Augmented Food Is MedicineN/A25 mi
REAL-Fam Feasibility Study for Youth Diabetes ManagementN/A25 mi
Fenofibrate for Prevention of DR WorseningPhase 325 mi
Transformative Research in Diabetic Nephropathy—25 mi
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and DiabetesN/A25 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesPhase 225 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 225 mi
Rare and Atypical Diabetes Network—25 mi
Registry for Stage 2 Type 1 Diabetes—25 mi
HLA Demographics Study in Adults With Type 1 Diabetes—25 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 325 mi
Preventing Type 2 Diabetes in Black Emergent AdultN/A25 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersN/A25 mi
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)N/A25 mi
Healthy Living Anson StudyN/A25 mi
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)Phase 449 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.